Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Revance Therapeutics
- 08 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Dec 2015 Interim results published in a Revance Therapeutics media release.
- 08 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History